Home
Latest News
Position Statements
1099-MISC Reporting Expansion
Card Check
DEA Rules and Enforcement/Suspicious Orders Monitoring
Drug Disposal
Impact of Gross Receipts Tax on Pharmaceutical Distributors
Importation of Prescription Medicines
Licensing Healthcare Distributors
LIFO Repeal
Marketing and Gift Restrictions
Voter Resources
Return to HDMA Homepage
Latest News
FBI: Chiropractor planning escape arrested
-
Daytona Beach News-Journal
- May 19, 2012
Denver theater review: LIDA Project's surreal "Auto da Fé"
-
Denver Post
- May 18, 2012
For Cumulus Media, Huckabee Takes On Limbaugh
-
BusinessWeek
- May 17, 2012
Voter Resources
Early / Absentee Voting Information
My Elected Officials
Overseas Voting Information
Register to Vote
My Candidates
Featured Issues
1099-MISC Reporting Expansion
Card Check
DEA Rules and Enforcement/Suspicious Orders Monitoring
Drug Disposal
Impact of Gross Receipts Tax on Pharmaceutical Distributors
Importation of Prescription Medicines
Licensing Healthcare Distributors
LIFO Repeal
Marketing and Gift Restrictions
Medicare Average Sales Price
Credit for Returns
Uniform Federal Pharmaceutical Pedigree
Filing Deadline for Presidential Primary Ballot Access (All Others)
March 23, 2012
<- Go Back
Quick Poll
What issue do you think is the most important challenge facing business this year?
Healthcare
Labor
Economic Stimulus
Energy Policy
Show Results
Healthcare (3 votes)
75%
Labor (1 votes)
25%
Return To Poll
Legislative Tracking
S. 733: A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
H.R. 2245: Preserving Access to Life-Saving Medications Act of 2011
S. 319: Pharmaceutical Market Access and Drug Safety Act of 2011
H.R. 2495: Tax Equity and Middle Class Fairness Act of 2011
S. 1002: SAFE DOSES Act
H.R. 1065: Pill Mill Crackdown Act of 2011
S. 296: Preserving Access to Life-Saving Medications Act
H.R. 905: To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.